Skip to search formSkip to main contentSkip to account menu

pafenolol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
BACKGROUND The potential absorption-limiting effect of intestinal efflux transporters such as P-glycoprotein (P-gp) has been well… 
2000
2000
OBJECTIVE The main aim of this study was to provide a simple, pharmacokinetic rationale for great similarity in the extent (Fab… 
1993
1993
The elimination of [3H]pafenolol and metabolites was investigated in fasted and fed rats. Separate groups received intravenous… 
1990
1990
The pharmacokinetics of pafenolol were studied in eight young healthy individuals. The doses were 10 mg iv and 40 mg orally. Each… 
1990
1990
The pharmacokinetics of pafenolol were evaluated in 12 healthy subjects after administration of three single IV doses (5, 10, and… 
1990
1990
The pharmacokinetics of pafenolol, a highly selective beta 1-adrenoceptor antagonist, have been studied in starved and unstarved… 
1985
1985
To test the usefulness of noninvasive ambulatory 24-hour blood pressure recording, the Del Mar Avionics system was used in a… 
1985
1985
Summary: We characterized the β-adrenoceptor subtype in isolated ring preparations of small intramyocardial flow-regulating…